These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 17113340)
1. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340 [TBL] [Abstract][Full Text] [Related]
2. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334 [TBL] [Abstract][Full Text] [Related]
3. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands. Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172 [TBL] [Abstract][Full Text] [Related]
4. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. Mrhalová M; Kodet R; Strnad P Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908 [TBL] [Abstract][Full Text] [Related]
5. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112 [TBL] [Abstract][Full Text] [Related]
6. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641 [TBL] [Abstract][Full Text] [Related]
7. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
12. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462 [TBL] [Abstract][Full Text] [Related]
13. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857 [TBL] [Abstract][Full Text] [Related]
15. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285 [TBL] [Abstract][Full Text] [Related]
16. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1. Mrhalova M; Kodet R Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059 [TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864 [TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Bringuier PP; Tamimi Y; Schuuring E; Schalken J Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895 [TBL] [Abstract][Full Text] [Related]
19. Expression of beta-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland. Daa T; Kaku N; Kashima K; Nakayama I; Yokoyama S J Exp Clin Cancer Res; 2005 Mar; 24(1):83-7. PubMed ID: 15943036 [TBL] [Abstract][Full Text] [Related]
20. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]